A drug newly approved by the UAE for the treatment of heart failure is being used in some hospitals.
The Emirates Drug Establishment announced on Monday it had authorised the use of Inpefa (sotagliflozin), a treatment shown in clinical trials to reduce deaths linked to cardiovascular disease as well as hospital admissions and urgent medical visits for heart failure.
Heart failure, a chronic condition in which the heart cannot pump blood effectively, is a growing problem in the UAE, driven by high rates of diabetes, hypertension and coronary artery disease.
Dr Brajesh Mittal, head of cardiology at Medcare Hospital Al Safa, said the drug was already being used in some settings.
“In our hospital, it is available and being prescribed, and some patients have already started treatment,” he said, before adding trial data showed meaningful re
Continue Reading on The National UAE
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.